Theracryf annual diluted eps
Diluted EPSBasic EPS
2022
2023
2024
2025
Theracryf EPS History: Annual & Quarterly (TCF)
Theracryf's diluted EPS was -£0.00 for fiscal 2025.
View full Theracryf company overviewTheracryf annual diluted eps history
| Fiscal year | Period ended | Diluted EPS | Basic EPS | Change | Growth |
|---|---|---|---|---|---|
| 2025 | 2025-03-31 | -£0.00 | -£0.00 | £0.01 | — |
| 2024 | 2024-03-31 | -£0.01 | -£0.01 | £0.00 | — |
| 2023 | 2023-03-31 | -£0.01 | -£0.01 | -£0.00 | — |
| 2022 | 2022-03-31 | -£0.01 | -£0.01 | — | — |
Theracryf diluted eps trends
Between the periods ended 2022-03-31 and 2025-03-31, Theracryf's diluted eps increased from -£0.01 to -£0.00, a change of £0.01.
About the metric
What earnings per share (EPS) means
Earnings per share (EPS) shows how much profit or loss is attributable to each common share. Diluted EPS includes the potential effect of convertible securities, options, and other instruments that could increase the share count, while basic EPS uses the weighted-average common shares actually outstanding.
Calculation and source
reported diluted and basic EPS
TickerStat displays diluted and basic earnings per share from official filings. Historical EPS values are adjusted to the current share basis when reported stock-split conversion ratios are available; they are not analyst estimates or earnings forecasts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Theracryf source filings ↗Community posts
TheraCryf approves £1.05m capital raise and share-capital reorganisation
TheraCryf confirmed on 7 September 2026 that shareholders approved its approximately £1.05m gross capital raise and the related subdivision of share capital. Shares and dates The placing and subscription will issue 583,333,328 new ordinary ...